Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study ; volume:21 ; number:1 ; day:14 ; month:8 ; year:2021 ; pages:1-8 ; date:12.2021
BMC ophthalmology ; 21, Heft 1 (14.8.2021), 1-8, 12.2021
- Urheber
-
Corazza, Paolo
D’Alterio, Francesco Maria
Kabbani, Jamil
Alam, Mostafa Mohamed Ragheb
Mercuri, Stefano
Orlans, Harry Otway
Younis, Saad
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-021-02055-6
- URN
-
urn:nbn:de:101:1-2021110319521574587951
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Corazza, Paolo
- D’Alterio, Francesco Maria
- Kabbani, Jamil
- Alam, Mostafa Mohamed Ragheb
- Mercuri, Stefano
- Orlans, Harry Otway
- Younis, Saad
- SpringerLink (Online service)
Ähnliche Objekte (12)
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture